Additional information
| Active substance | Ticagrelor |
|---|---|
| Water Retention | None |
| Hepatotoxicity | Low risk |
| Lab Test | Not specific, may monitor platelet function tests |
| Also known as | AZD6140 |
| Blood pressure | Can cause transient increase |
| Trade name | Brilinta, Brilique, Possia |
| FORM | 56 pills x 90 mg |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | (1S,2S,3R,5R)-3-[7-[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino]-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Formula | C23H28F2N6O4S |
| Substance class | Antiplatelet agent |
| Main action | Platelet aggregation inhibitor |
| Half-life | Approximately 7 to 8.5 hours |
| Dosage (medical) | Typically 90 mg twice daily |
| Dosage (sports) | Not applicable |
| Effects | Reduces the rate of stent thrombosis in patients who are at risk, decreases myocardial infarction |
| Side effects | Bleeding, dyspnea, headache, cough, hypertension, nausea |
| Use in sports | Not typically used in sports |
| Manufacturer | AstraZeneca |
FEMAMED 2.5 DEUS MEDICAL
Anastrazole HEMI PHARMA
Balkan Pharma Anapolon 50 mg 60 Tabletten
Femara 2.5 Mg Novartis
Intex Primobolan 25mg Intex Pharma
Balkan Pharma Danabol 10 mg 100 Tabletten
Champix Starter Pack Pfizer
Zimaks 400 Bilim 

Reviews
There are no reviews yet.